Company / Capital Returned to Shareholders
Fortress Biotech, Inc. Capital Returned to Shareholders History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$694.0K
FY2025
5-year range
$307.0K / $749.0K
FY2021-FY2025
Trend
-5.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $749,000 to $694,000 over the past 2 years.
Based on SEC 10-K filings.
$694,000 in FY2025 with a 3-year CAGR of -2.5%.
Declined from $749,000 to $694,000 over the past 2 years.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -2.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -2.5%, indicating a declining trend.
- In FY2025, capital returned to shareholders decreased 5.7% year-over-year.
- Peak capital returned to shareholders was recorded in FY2023.
- Lowest capital returned to shareholders in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $694.0K | -5.7% |
| FY2024 | $736.0K | -1.7% |
| FY2023 | $749.0K | +0.0% |
| FY2022 | $749.0K | +144.0% |
| FY2021 | $307.0K | - |
| FY2020 | $0 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026